Abstract Details

Title Salvage Chemotherapy with Bevacizumab for Recurrent Alkylator-Refractory Anaplastic Astrocytoma

Topic Neurometabolic Disorders/Neurotoxicology/Neuroendocrinology

Presentation(s) (-)

Poster/Presentation
Number 005

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Marc Chamberlain, MD (Cascadian Therapeutics)	No disclosure on file
	No disclosure on file
Saud Sadiq, BS, F�鶹��ýӳ�� (Tisch Multiple Sclerosis Research Center of New York)	Ms. Brewi has nothing to disclose.
	No disclosure on file